Enza Biotech AB was founded in 2012 as a spin-off company based on results from a research programme coordinated by Lund University. The fruitful collaboration between biotechnology researchers and materials scientists resulted in the design of a production process for a completely novel type of nonionic surfactants, the oligomeric alkylglycosides, OLMAG surfactants. Such molecular structures had earlier been identified as possible candidates for replacing polysorbate in the pharmaceutical industry, and many attempts to synthesise them were made without success. It was not until an enzymatic synthesis route was designed that they could be produced and their excellent properties were verified.

Even though the need for the oligomeric alkylglycosides was first identified in the pharmaceutical field, and the molecular structure was designed with the aim of replacing polysorbate, the oligomeric alkylglycosides also meet the demand for green and biobased nonionic surfactants in the cosmetics and personal care sector.

Business angel investment.
Continued development of cost-efficient process and scaling up.

Received SME instrument, stage 1 grant.
Was awarded a grant from the Sten K Johnson foundation.
Patent application on surface active composition filed.
Development of cost-efficient production process.

Forska&Väx B grant received from Vinnova, Sweden’s Innovation Agency.
Verification testing of the oligomeric alkylglycosides.
Started consulting in Biotechnology.

Enza Biotech was founded by Maria Andersson, Stefan Ulvenlund, Patrick Adlercreutz and Eva Nordberg Karlsson.
Received IKS accelerator grant.
Rented facilities at Chemical Center in Lund.

PhD thesis defended by David Svensson on “Enzymatic production of oligomeric alkylglycosides”.

Patent application on the enzymatic production process filed.

Research collaboration initiated as PhD project on “Enzymatic production of oligomeric alkylglycosides” within the research programme Greenchem, financed by Mistra. Project supervised by Patrick Adlercreutz and performed at Division of Biotechnology at Lund University.

Research initiated by Stefan Ulvenlund (co-founder of Enza) on alternative solubilisers for nasal administration and later alternative dispersants for pulmonary administration, leading to findings of relationship between surfactant structure and mildness and non-irritancy.